Izabela Florek

423 total citations
14 papers, 346 citations indexed

About

Izabela Florek is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Izabela Florek has authored 14 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 7 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in Izabela Florek's work include Chronic Myeloid Leukemia Treatments (7 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Acute Myeloid Leukemia Research (3 papers). Izabela Florek is often cited by papers focused on Chronic Myeloid Leukemia Treatments (7 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Acute Myeloid Leukemia Research (3 papers). Izabela Florek collaborates with scholars based in Poland, Italy and Germany. Izabela Florek's co-authors include Anna Zdzienicka, John P. Cooke, Andrzej Szuba, Anna K. Wójtowicz, Józef Dulak, Alicja Józkowicz, Ibeth Guevara, A. Dembińska-Kieć, Tomasz Sacha and Aleksander B. Skotnicki and has published in prestigious journals such as Blood, Arteriosclerosis Thrombosis and Vascular Biology and Frontiers in Oncology.

In The Last Decade

Izabela Florek

14 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Izabela Florek Poland	4	167	77	62	52	49	14	346
Dennis E. Busler United States	9	205 1.2×	118 1.5×	80 1.3×	64 1.2×	56 1.1×	10	587
Azeb Haile United States	10	243 1.5×	98 1.3×	40 0.6×	46 0.9×	43 0.9×	17	555
Zaki Al‐Yafeai United States	9	164 1.0×	35 0.5×	44 0.7×	39 0.8×	39 0.8×	18	369
Michael Reynolds United States	10	230 1.4×	73 0.9×	74 1.2×	33 0.6×	73 1.5×	15	420
Nina Tsakadze United States	8	111 0.7×	43 0.6×	39 0.6×	34 0.7×	41 0.8×	19	403
Brooke Henderson United States	8	137 0.8×	47 0.6×	65 1.0×	123 2.4×	45 0.9×	11	361
Aneta Radziwon‐Balicka Denmark	14	177 1.1×	41 0.5×	106 1.7×	75 1.4×	68 1.4×	19	518
Masaki Fujimoto Japan	12	376 2.3×	78 1.0×	56 0.9×	33 0.6×	71 1.4×	25	597
Vitali Shilo Israel	8	192 1.1×	54 0.7×	90 1.5×	15 0.3×	43 0.9×	8	399
K Shimizu Japan	8	88 0.5×	89 1.2×	42 0.7×	76 1.5×	79 1.6×	17	510

Countries citing papers authored by Izabela Florek

Since Specialization

Citations

This map shows the geographic impact of Izabela Florek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Izabela Florek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Izabela Florek more than expected).

Fields of papers citing papers by Izabela Florek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Izabela Florek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Izabela Florek. The network helps show where Izabela Florek may publish in the future.

Co-authorship network of co-authors of Izabela Florek

This figure shows the co-authorship network connecting the top 25 collaborators of Izabela Florek. A scholar is included among the top collaborators of Izabela Florek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Izabela Florek. Izabela Florek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Canzian, Federico, Joanna Góra‐Tybor, Daniele Campa, et al.. (2022). Impact of genetic polymorphisms of drug transporters ABCB1 and ABCG2 and regulators of xenobiotic transport and metabolism PXR and CAR on clinical efficacy of dasatinib in chronic myeloid leukemia. Frontiers in Oncology. 12. 952640–952640. 3 indexed citations

Bujko, Mateusz, Paulina Kober, Marta Libura, et al.. (2015). Promoter DNA methylation and expression levels of HOXA4, HOXA5 and MEIS1 in acute myeloid leukemia. Molecular Medicine Reports. 11(5). 3948–3954. 16 indexed citations

Bujko, Mateusz, Paulina Kober, Marta Libura, et al.. (2014). Comparison of promoter DNA methylation and expression levels of genes encoding CCAAT/enhancer binding proteins in AML patients. Leukemia Research. 38(7). 850–856. 18 indexed citations

Sacha, Tomasz, et al.. (2014). [Atypical BCR-ABL transcripts in patients with chronic myeloid leukemia--the scheme for the diagnosis and monitoring of minimal residual disease].. PubMed. 71(5). 258–62. 3 indexed citations

Piątkowska‐Jakubas, Beata, et al.. (2012). Monitorowanie kinetyki zmian wczesnego chimeryzmu hematopoetycznego i charakterystyka wszczepienia molekularnego za pomocą metody STR-PCR u pacjentów poddanych alloHSCT. Acta Haematologica Polonica. 43(4). 361–368. 1 indexed citations

Sacha, Tomasz, et al.. (2011). [H-oCT1 gene expression as a predictor of major and complete molecular response to imatinib of chronic myeloid leukemia. Single center experience].. PubMed. 68(4). 191–5. 1 indexed citations

Sacha, Tomasz, Joanna Dulińska-Litewka, Marek Bodzioch, et al.. (2011). [Beta-carotene regulates the expression of proapoptotic BAX and CAPN2 in HL-60, U-937 and TF-1 - human acute myeloid leukemia cell lines; microarray, RQ-PCR and Western Blot analysis].. PubMed. 68(5). 258–62. 2 indexed citations

Sacha, Tomasz, et al.. (2010). [Evaluation of hematopoietic chimerism after allogeneic bone marrow transplantation by modern molecular techniques (STR-PCR and RQ-PCR)--single center].. PubMed. 67(12). 1282–91. 3 indexed citations

Florek, Izabela, et al.. (2010). [Implementation of direct sequencing as a method of ABL gene mutations analysis in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitor].. PubMed. 67(12). 1292–7. 1 indexed citations

10.

Sacha, Tomasz, Izabela Florek, Martin Mueller, et al.. (2010). [Standardization of quantitative detection of BCR-ABL gene expression by RQ-PCR in patients with chronic myeloid leukemia in cooperation with European Leukemia Net].. PubMed. 67(7). 454–9. 3 indexed citations

11.

Sacha, Tomasz, et al.. (2009). Wilms' tumor gene 1 expression analysis by real-time quantitative polymerase chain reaction for monitoring of minimal residual disease in acute leukemia. Leukemia & lymphoma. 50(8). 1326–1332. 20 indexed citations

12.

Sacha, Tomasz, et al.. (2009). Prognostic Factors in Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors- Single Center Experience.. Blood. 114(22). 2210–2210. 2 indexed citations

13.

Molimard, Mathiéu, et al.. (2008). Imatinib Trough Plasma Concentration and Its Correlation with Clinical Response in Chronic Phase and Accelerated Phase of CML. Blood. 112(11). 4269–4269. 2 indexed citations

14.

Dulak, Józef, Alicja Józkowicz, A. Dembińska-Kieć, et al.. (2000). Nitric Oxide Induces the Synthesis of Vascular Endothelial Growth Factor by Rat Vascular Smooth Muscle Cells. Arteriosclerosis Thrombosis and Vascular Biology. 20(3). 659–666. 271 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact